论文部分内容阅读
乳腺癌涉及癌症死亡,是全世界妇女共同关心的问题,为此对1980年以来10年间世界范围内,有关避孕药和绝经后替代治疗所含孕激素与乳腺癌间关系的文献进行了回顾,显示孕激素对乳腺组织的生物学机制,尚无一致意见,而复方OC_s和替代治疗中均混淆了雌激素的影响,有待于对新剂型孕激素(如炔诺酮庚酸酯注射针,释放LNG的IUD和埋植剂)的潜在高危病例进一步研究,以阐明孕激素与乳腺癌间的关系。
Breast cancer, which involves the death of cancer, is a common concern for women all over the world. To review the literature about the relationship between progestin and breast cancer in contraceptives and postmenopausal replacement therapy in the world over the 10 years since 1980, There is no consensus on the biological mechanism of progestin on breast tissue, and the effects of estrogen on compound OC_s and replacement therapy are confused, and the effects of estrogen on new dosage forms of progestin (such as norethindrone heptanoate injection needle, release LNG IUDs and implants) to further elucidate the relationship between progesterone and breast cancer.